Sumagen’s World First Killed Whole HIV Vaccine Set For Phase II
Executive Summary
After a positive outcome from a US Phase I study, South Korea's Sumagen is stepping closer to the launch of the world's first killed-whole HIV vaccine with potential to both prevent and treat AIDS.